Associate Professor of Medicine, Massachusetts General Hospital
Nephrology
Dr. Herbert Y. Lin, MD
|
|
Give Review
Herbert Y. Lin, MD works in the field of Nephrology. He graduated from Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care He has 2 awards "Elected Member" and "Fellow (ASNF)". Herbert is a published doctor. He published 53 publications, including: 'Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated With iron overload and progressive liver disease.
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
- BuMPing iron With modified heparins.
- Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating TH1 Adaptive Immunity.
- The liver: conductor of systemic iron regulation.
- Differential regulation of myeloid leukemias by the bone marrow microenvironment.
- Local proliferation dominates lesional macrophage accumulation in atherosclerosis.
- The effect of timing of oral meloxicam administration on physiological responses in calves after cautery dehorning With local anesthesia.
- A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum.
- A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced Kidney disease model of anemia in rats.
- Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin.
- Repulsive Guidance Molecule (RGM) Family Proteins Exhibit Differential Binding Kinetics for Bone Morphogenetic Proteins (BMPs).
- Divergent roles of Smad3 and PI3-kinase in murine adriamycin Nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.
- Mechanisms of Anemia in CKD.
- Transforming Growth Factor-β and the Kidney Revisited: Introduction.
- The BMP Coreceptor RGMb Promotes While the Endogenous BMP Antagonist Noggin Reduces Neurite Outgrowth and Peripheral Nerve Regeneration by Modulating BMP Signaling.
- Visualizing Microtubule-Dependent Vasopressin Type 2 Receptor Trafficking Using a New High-Affinity Fluorescent Vasopressin Ligand.
- The molecular pathogenesis of hereditary hemochromatosis.
- Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice Without transferrin receptor 2 or Hfe.
- Pharmacologic inhibition of hepcidin expression reverses anemia of Chronic disease in rats.
- Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.
- The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel Disease.
- Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages.
- BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model.
- BMP signaling modulates hepcidin expression in zebrafish embryos independent of hemojuvelin.
- Altered hepatic BMP signaling pathway in human HFE hemochromatosis.
- BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice.
- Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.
- Dragon enhances BMP signaling and increases transepithelial resistance in Kidney epithelial cells.
- Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice.
- Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.
- BMP6 is a key endogenous regulator of hepcidin expression and iron Metabolism.
- Effects of the Renal medullary pH and ionic environment on vasopressin binding and signaling.
- Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron Metabolism.
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.
- Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
- Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.
- Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic Nephropathy: amelioration by soluble TGF-beta ...
- Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
- Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.
- Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis.
- Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.
- DRAGON, a bone morphogenetic protein co-receptor.
- Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.
- BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo.
- In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
- DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive ...
- Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells.
- Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-beta-induced nuclear accumulation.
- Inflammation Regulates TMPRSS6 Expression via STAT5.
- The role of TMPRSS6/matriptase-2 in iron regulation and anemia.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Mass Gen Hospital
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Glomerulonephritis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Elected Member
- Fellow (ASNF)
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Massachusetts Eye and Ear Infirmary -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1245211960 | |
| NPPES Provider LastName | LIN | |
| NPPES Provider FirstName | HERBERT | |
| NPPES Provider ZIPCode | 021142696 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 211.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245211960 |
| Last Name Of The Provider | LIN |
| First Name Of The Provider | HERBERT |
| View All |
Similar Doctors
|
|
Dr. Eugene P. Rhee, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Martina M. McGrath, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Ross, MD |
|
|
Dr. Andrew S. Allegretti, MD |
|
|
Dr. Robert S. Brown, MD |
|
|
Dr. Ranil N. Desilva, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean M. Francis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Narittaya Varothai, MD |
|
|
Dr. Osama Amro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivian E. Abernethy, MD
This Doctor is OpenDoctor Recommended.
|